Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers

被引：0

作者：

Muddu, V. ^{[1
]}

Shah, A. ^{[2
]}

Raj, A. ^{[3
]}

Bahl, A. ^{[4
]}

Thirumalairaj, R. ^{[5
]}

Ghosh, J. ^{[6
]}

Ostwal, V. ^{[2
]}

Rajappa, S. ^{[7
]}

Vora, A. ^{[8
]}

Lavingia, V. ^{[9
]}

Sharma, A. ^{[10
]}

Khan, A. ^{[1
]}

Rohatgi, N. ^{[4
]}

Mahajan, M. ^{[11
]}

Chandrakanth, M. ^{[6
]}

Ramaswamy, A. ^{[12
]}

机构：

[1] AIG Hosp, Hyderabad, India

[2] Tata Mem Hosp, Tata Mem Ctr, Mumbai, Maharashtra, India

[3] Sarvodaya Hosp, Faridabad, India

[4] Fortis Canc Inst, Gurgaon, India

[5] Apollo Canc Ctr, Chennai, Tamil Nadu, India

[6] Tata Med Ctr, Kolkata, India

[7] Basavatarakam Indo Amer Canc Hosp, Hyderabad, India

[8] HOPE Oncol Care Clin, New Delhi, India

[9] HCG Canc Ctr, Ahmadabad, Gujarat, India

[10] All India Inst Med Sci, New Delhi, India

[11] Pacific Med Coll Hosp, Udaipur, Rajasthan, India

[12] Tata Mem Hosp, Mumbai, Maharashtra, India

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.265

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-209

引用

下载

页码：S90 / S90

页数：1

共 50 条

[1] Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Alexander Olkus
Aurelie Tomczak
Anne Katrin Berger
Conrad Rauber
Philip Puchas
Cyrill Wehling
Thomas Longerich
Arianeb Mehrabi
De-Hua Chang
Jakob Liermann
Sophia Schäfer
Jan Pfeiffenberger
Dirk Jäger
Patrick Michl
Christoph Springfeld
Michael T. Dill
Targeted Oncology, 2024, 19 : 213 - 221
[2] Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Olkus, Alexander
Tomczak, Aurelie
Berger, Anne Katrin
Rauber, Conrad
Puchas, Philip
Wehling, Cyrill
Longerich, Thomas
Mehrabi, Arianeb
Chang, De-Hua
Liermann, Jakob
Schaefer, Sophia
Pfeiffenberger, Jan
Jaeger, Dirk
Michl, Patrick
Springfeld, Christoph
Dill, Michael T.
TARGETED ONCOLOGY, 2024, 19 (02) : 213 - 221
[3] Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
Rizzo, Alessandro
Salati, Massimiliano
Frega, Giorgio
Merz, Valeria
Caputo, Francesco
Di Federico, Alessandro
Palloni, Andrea
Carloni, Riccardo
Ricci, Angela Dalia
Gadaleta-Caldarola, Gennaro
Messina, Carlo
Spallanzani, Andrea
Gelsomino, Fabio
Benatti, Stefania
Luppi, Gabriele
Melisi, Davide
Dominici, Massimo
Brandi, Giovanni
MEDICINA-LITHUANIA, 2022, 58 (11):
[4] The survival impact of the addition of durvalumab to cisplatin/gemcitabine in advanced biliary tract cancer: A real-world, retrospective, multicentric study
Rimini, M.
Persano, M.
Foti, S.
Fornaro, L.
Lonardi, S.
Niger, M.
Tamburini, E.
Lavacchi, D.
Rapposelli, I. G.
Martinelli, E.
Garajova, I.
Simionato, F.
Camera, S.
Rossari, F.
Amadeo, E.
Vitiello, F.
Cascinu, S.
Rimassa, L.
Antonuzzo, L.
Gardini, A. Casadei
ANNALS OF ONCOLOGY, 2023, 34 : S1528 - S1528
[5] Real-world experience supporting the role of oncologic resection and adjuvant chemotherapy in biliary tract cancers
Boutin, Melina
Krishnan, Tharani
Safro, Maria
Yang, Jenny
Jafari, Helia
Davies, Janine M.
Gill, Sharlene
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
[6] Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data
Rimini, Margherita
Fornaro, Lorenzo
Lonardi, Sara
Niger, Monica
Lavacchi, Daniele
Pressiani, Tiziana
Lucchetti, Jessica
Giordano, Guido
Pretta, Andrea
Tamburini, Emiliano
Pirrone, Chiara
Rapposelli, Ilario Giovanni
Diana, Anna
Martinelli, Erika
Garajova, Ingrid
Simionato, Francesca
Schirripa, Marta
Formica, Vincenzo
Vivaldi, Caterina
Caliman, Enrico
Rizzato, Mario Domenico
Zanuso, Valentina
Nichetti, Federico
Angotti, Lorenzo
Landriscina, Matteo
Scartozzi, Mario
Ramundo, Matteo
Pastorino, Alessandro
Daniele, Bruno
Cornara, Noemi
Persano, Mara
Gusmaroli, Eleonora
Cerantola, Riccardo
Salani, Francesca
Ratti, Francesca
Aldrighetti, Luca
Cascinu, Stefano
Rimassa, Lorenza
Antonuzzo, Lorenzo
Casadei-Gardini, Andrea
LIVER INTERNATIONAL, 2023, 43 (08) : 1803 - 1812
[7] Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data
Rimini, M.
Fornaro, L.
Lonardi, S.
Niger, M.
Lucchetti, J.
Giordano, G.
Scartozzi, M.
Tamburini, E.
Rapposelli, I.
Martinelli, E.
Garajova, I.
Schirripa, M.
Rimassa, L.
Antonuzzo, L.
Gardini, A. Casadei
ANNALS OF ONCOLOGY, 2023, 34 : S28 - S28
[8] Single-center real-world experience from 18 consecutive cases treated with durvalumab in combination with chemotherapy for advanced biliary tract cancer
Zhang, D.
Heinemann, V.
Haas, M.
Heinrich, K.
Weiss, L.
Boukovala, M.
Probst, V.
Anna, R.
Beyer, G.
von Bergwelt-Baldion, M.
Westphalen, B.
Boeck, S.
Dorman, K.
ANNALS OF ONCOLOGY, 2023, 34 : S42 - S42
[9] A phase II study of tremelimumab, durvalumab, and bevacizumab in advanced biliary tract cancers
Coffman, Kelley Lauren
Xie, Changqing
Hrones, Donna M.
Monge, B. M. Cecilia
Kleiner, David E.
Steinberg, Seth M.
Redd, Bernadette
Wood, Brad J.
Kassin, Michael
Levy, Elliot
Benmebarek, Mohamed-Reda
Greten, Tim F.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[10] Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort
Mitzlaff, Katharina
Kirstein, Martha M.
Mueller, Christian
Venerito, Marino
Olkus, Alexander
Dill, Michael T.
Weinmann, Arndt
Kocheise, Lorenz
Busch, Alina
Schulze, Kornelius
Allo, Gabriel
Waldschmidt, Dirk-Thomas
Barsch, Maryam
Bengsch, Bertram
Quante, Michael
Gonzalez-Carmona, Maria A.
Himmelsbach, Vera
Finkelmeier, Fabian
Kloeckner, Roman
Schirmacher, Peter
Marquardt, Jens U.
Zimpel, Carolin
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024,

← 1 2 3 4 5 →